Target intelligence / Profile preview

G-quadruplex DNA structure at G4-duplex junction (G4-duplex junction)

Target
G4-duplex junction
Molecular classification
Non-canonical DNA structure, Nucleic acid secondary structure, G-quadruplex
01

Overview

G-quadruplex (G4) DNA structures are non-canonical, four-stranded secondary structures formed in guanine-rich sequences through Hoogsteen hydrogen bonding (MDPI, 2021; NIH, 2023). These structures are highly prevalent in the promoter regions of key oncogenes such as MYC, BCL2, and KRAS, where they often exist at the junction between the G4 motif and the flanking duplex DNA (MDPI, 2017; NIH, 2021). The G4-duplex junction represents a unique structural interface that can be specifically targeted by small molecules to modulate gene expression (NIH, 2021). Stabilization of these structures typically acts as a transcriptional repressor, preventing the binding of transcription factors or the progression of RNA polymerase, thereby downregulating oncogene expression (IntechOpen, 2013; MDPI, 2017). Beyond transcription, G4 structures at these junctions are involved in DNA replication and genome stability, making them attractive targets for cancer therapy (NIH, 2013; NIH, 2021). Drugs like CX-5461 and various G4 ligands aim to stabilize these structures to induce replication stress and apoptosis in cancer cells, often exploiting synthetic lethal relationships in DNA repair-deficient tumors (PNAS, 2012; NIH, 2021).

Other names
G-quadruplexG4G4-duplex hybridPromoter G-quadruplexNon-canonical DNA structureTetraplex DNAG-quadruplex-duplex interface
02

Mechanism of action

Stabilization of G-quadruplex structures at promoter regions to inhibit oncogene transcription, induction of replication stress, and inhibition of telomerase activity (NIH, 2023; MDPI, 2017).

03

Biological functions

Transcription regulationDNA replicationGenome maintenanceTelomere regulationEpigenetic regulation
04

Disease associations

CancerNeurodegenerative diseaseViral infection
05

Safety considerations

Genomic instabilityOff-target DNA bindingReplication stress in normal cellsPotential for chromosomal rearrangements (PNAS, 2012; MDPI, 2021).
06

Interacting drugs

Pidnarulex (CX-5461)

9 more in the full profile.

07

Biomarkers

BRCA1/2 mutation statusMYC expression levelsγH2AX (DNA damage marker)G4-seq genomic mapping

Beyond the preview

Go deeper on G-quadruplex DNA structure at G4-duplex junction (G4-duplex junction).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G-quadruplex DNA structure at G4-duplex junction (G4-duplex junction).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call